MarketWatch: “Nasdaq rebalancing is coming, and it’s boosting interest in Friday’s $2.3 trillion option expiration” - DataTrek Research
08 Aug
Facebook Twitter Google Linkedin Pinterest

Trial DataTrek Morning Briefings for Free

Thousands of investors and financial journalists rely on Nick and Jessica’s newsletter every day for their thought-provoking work on markets, data and disruption. See why for yourself by starting a 2-week FREE trial below.


By clicking submit, you agree that you have read and understand our Terms of Service, Subscription Agreement, and Privacy Policy, and hereby agree to be bound by them.

MarketWatch: “Nasdaq rebalancing is coming, and it’s boosting interest in Friday’s $2.3 trillion option expiration”

By datatrekresearch in IN THE NEWS MarketWatch: “Nasdaq rebalancing is coming, and it’s boosting interest in Friday’s $2.3 trillion option expiration”

Excerpt from MarketWatch quoting DataTrek co-founder Nick Colas:

.... "If the rally in Big Tech stocks does falter, history suggests it won’t be because of the rebalancing.

Here’s more on that from Nicholas Colas, co-founder of DataTrek Research, who discussed the topic in commentary emailed to MarketWatch on Wednesday.

“…[T]here is the natural inclination to think that the upcoming special reweighting is a sign that large cap disruptive tech is set to roll over because a handful of names have so handily outpaced the rest of its notional peers,” Colas said.

“History suggests otherwise. The last 2 one-off reweights were in 2011 and 1998. Neither proved to be the end of a Nasdaq 100/tech stock bull market. Not even close, really"....

Full article here on MarketWatch.

Trial DataTrek Morning Briefings for Free

Thousands of investors and financial journalists rely on Nick and Jessica’s newsletter every day for their thought-provoking work on markets, data and disruption. See why for yourself by starting a 2-week FREE trial below.


By clicking submit, you agree that you have read and understand our Terms of Service, Subscription Agreement, and Privacy Policy, and hereby agree to be bound by them.